{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:12:30Z","timestamp":1790856750220,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Higher Education Long Term Research Grant Scheme","award":["RMI\/ST\/LRGS5\/3 (2\/2011)"],"award-info":[{"award-number":["RMI\/ST\/LRGS5\/3 (2\/2011)"]}]},{"DOI":"10.13039\/501100013262","name":"Institute of Research Management and Innovation, Universiti Teknologi MARA","doi-asserted-by":"publisher","award":["[600-IRMI\/MYRA 5\/3\/MITRA (003\/20170)-1]"],"award-info":[{"award-number":["[600-IRMI\/MYRA 5\/3\/MITRA (003\/20170)-1]"]}],"id":[{"id":"10.13039\/501100013262","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education Fundamental Research Grant Scheme","award":["600-IRMI\/FRGS 5\/3 (067\/2019)"],"award-info":[{"award-number":["600-IRMI\/FRGS 5\/3 (067\/2019)"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Familial hypercholesterolaemia (FH) patients have elevated levels of low-density lipoprotein cholesterol, rendering them at high risk of premature coronary artery disease (PCAD). However, the FH prevalence among angiogram-proven PCAD (AP-PCAD) patients and their status of coronary risk factors (CRFs) have not been reported in the Asian population.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>This study aimed to (1) determine the prevalence of clinically diagnosed FH among AP-PCAD patients, (2) compare CRFs between AP-PCAD patients with control groups, and (3) identify the independent predictors of PCAD.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>AP-PCAD patients and FH patients without PCAD were recruited from Cardiology and Specialist Lipid Clinics. Subjects were divided into AP-PCAD with FH (G1), AP-PCAD without FH (G2), FH without PCAD (G3) and normal controls (G4). Medical records were collected from the clinic database and standardised questionnaires. FH was clinically diagnosed using Dutch Lipid Clinic Network Criteria.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 572 subjects were recruited (males:86.4%; mean<jats:underline>\u00b1<\/jats:underline>SD age: 55.6\u00b18.5years). The prevalence of Definite, Potential and All FH among AP-PCAD patients were 6%(19\/319), 16% (51\/319) and 45.5% (145\/319) respectively. G1 had higher central obesity, family history of PCAD and family history of hypercholesterolaemia compared to other groups. Among all subjects, diabetes [OR(95% CI): 4.7(2.9,7.7)], hypertension [OR(95% CI): 14.1(7.8,25.6)], FH [OR(95% CI): 2.9(1.5,5.5)] and Potential (Definite and Probable) FH [OR(95% CI): 4.5(2.1,9.6)] were independent predictors for PCAD. Among FH patients, family history of PCAD [OR(95% CI): 3.0(1.4,6.3)] and Definite FH [OR(95% CI): 7.1(1.9,27.4)] were independent predictors for PCAD.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Potential FH is common among AP-PCAD patients and contributes greatly to the AP-PCAD. FH-PCAD subjects have greater proportions of various risk factors compared to other groups. Presence of FH, diabetes, hypertension, obesity and family history of PCAD are independent predictors of PCAD. FH with PCAD is in very-high-risk category, hence, early management of modifiable CRFs in these patients are warranted.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0273896","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T17:41:22Z","timestamp":1662140482000},"page":"e0273896","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort"],"prefix":"10.1371","volume":"17","author":[{"given":"Sukma Azureen","family":"Nazli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-0087","authenticated-orcid":true,"given":"Yung-An","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Alicezah","family":"Mohd Kasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1144-4451","authenticated-orcid":true,"given":"Zaliha","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Bakhtiar","family":"Md Radzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairul Shafiq","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sazzli Shahlan","family":"Kasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhari","family":"Rosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4462-8484","authenticated-orcid":true,"given":"Hapizah","family":"Nawawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"issue":"5","key":"pone.0273896.ref001","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"MA Austin","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pone.0273896.ref002","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2015.04.809","article-title":"Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology","volume":"241","author":"G De Backer","year":"2015","journal-title":"Atherosclerosis"},{"key":"pone.0273896.ref003","first-page":"35949","article-title":"Translational research for improving the care of familial hypercholesterolemia: the \u201cTen Countries Study\u201d and beyond","author":"GF Watts","year":"2016","journal-title":"Journal of atherosclerosis and thrombosis"},{"key":"pone.0273896.ref004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2018.06.855","article-title":"Epidemiology of familial hypercholesterolaemia: Community and clinical","volume":"277","author":"AJ Vallejo-Vaz","year":"2018","journal-title":"Atherosclerosis"},{"key":"pone.0273896.ref005","article-title":"My HFHSI. Familial Hypercholesterolaemia in the Malaysian Community: Prevalence, Under-Detection and Under-Treatment","author":"YA Chua","year":"2021","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"pone.0273896.ref006","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12872-017-0694-z","article-title":"Diagnostic performance of various familial hypercholesterolaemia diagnostic criteria compared to Dutch lipid clinic criteria in an Asian population","volume":"17","author":"S Abdul-Razak","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"6807","key":"pone.0273896.ref007","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"303","author":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","year":"1991","journal-title":"BMJ"},{"issue":"2","key":"pone.0273896.ref008","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"RR Williams","year":"1993","journal-title":"Am J Cardiol"},{"issue":"12","key":"pone.0273896.ref009","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.5551\/jat.14621","article-title":"Guidelines for the management of familial hypercholesterolemia","volume":"19","author":"M Harada-Shiba","year":"2012","journal-title":"J Atheroscler Thromb"},{"issue":"22","key":"pone.0273896.ref010","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association","volume":"132","author":"SS Gidding","year":"2015","journal-title":"Circulation"},{"issue":"12","key":"pone.0273896.ref011","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cjca.2014.09.028","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia","volume":"30","author":"P Primary","year":"2014","journal-title":"Can J Cardiol"},{"issue":"9","key":"pone.0273896.ref012","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.cjca.2018.05.015","article-title":"Simplified Canadian Definition for Familial Hypercholesterolemia","volume":"34","author":"I Ruel","year":"2018","journal-title":"Can J Cardiol"},{"issue":"Suppl 1","key":"pone.0273896.ref013","first-page":"42","article-title":"A Review of Coronary Artery Disease Research in Malaysia","volume":"71","author":"CS Ang","year":"2016","journal-title":"Med J Malaysia"},{"issue":"8","key":"pone.0273896.ref014","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1253\/circj.CJ-13-0786","article-title":"Epidemiology of stroke and coronary artery disease","volume":"77","author":"J Hata","year":"2013","journal-title":"Asia. Circ J"},{"issue":"5","key":"pone.0273896.ref015","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","article-title":"Heart disease and stroke statistics\u20142007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"115","author":"W Rosamond","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"pone.0273896.ref016","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.pcad.2013.01.003","article-title":"Coronary angiography is the gold standard for patients with significant left ventricular dysfunction","volume":"55","author":"MJ Lim","year":"2013","journal-title":"Prog Cardiovasc Dis"},{"issue":"16","key":"pone.0273896.ref017","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"GK Hansson","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0273896.ref018","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4330\/wjc.v8.i12.728","article-title":"Newer perspectives of coronary artery disease in young","volume":"8","author":"A Aggarwal","year":"2016","journal-title":"World J Cardiol"},{"issue":"6","key":"pone.0273896.ref019","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1160\/TH08-05-0286","article-title":"Premature coronary artery disease: an inferred cardiovascular variant or a South Asian genetic disorder","volume":"99","author":"JV Patel","year":"2008","journal-title":"Thromb Haemost"},{"key":"pone.0273896.ref020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12872-015-0145-7","article-title":"Prevalence and risk factors of premature coronary artery disease in patients undergoing coronary angiography in Kurdistan, Iraq","volume":"15","author":"AM Mohammad","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"issue":"45","key":"pone.0273896.ref021","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"BG Nordestgaard","year":"2013","journal-title":"European heart journal"},{"issue":"3","key":"pone.0273896.ref022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_106_17","article-title":"Risk Factors for Coronary Artery Disease","volume":"18","author":"R. Hajar","year":"2017","journal-title":"Historical Perspectives. Heart Views"},{"issue":"4","key":"pone.0273896.ref023","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cjca.2018.01.004","article-title":"Myocardial infarction with no obstructive coronary artery disease: angiographic and clinical insights in patients with premature presentation","volume":"34","author":"V Raparelli","year":"2018","journal-title":"Canadian Journal of Cardiology"},{"issue":"2","key":"pone.0273896.ref024","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjcard.2012.02.066","article-title":"A computed tomography-based coronary lesion score to predict acute coronary syndrome among patients with acute chest pain and significant coronary stenosis on coronary computed tomographic angiogram","volume":"110","author":"M Ferencik","year":"2012","journal-title":"Am J Cardiol"},{"issue":"9867","key":"pone.0273896.ref025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"FW Mohr","year":"2013","journal-title":"Lancet"},{"key":"pone.0273896.ref026","author":"Ministry of Health Malaysia AoMM, National Heart Association of Malaysia","year":"2017","journal-title":"5th Edition of clinical practice guidelines on management of dyslipidaemia 2017 Ministry of Health"},{"key":"pone.0273896.ref027","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2147\/COPD.S141295","article-title":"Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients","volume":"12","author":"JU Lim","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"pone.0273896.ref028","author":"Organization WH","year":"2011","journal-title":"Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8\u201311 December 2008"},{"issue":"6","key":"pone.0273896.ref029","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jacl.2016.08.011","article-title":"Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions","volume":"10","author":"KL Ellis","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"5","key":"pone.0273896.ref030","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association","volume":"73","author":"P Muntner","year":"2019","journal-title":"Hypertension"},{"issue":"2","key":"pone.0273896.ref031","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ene.13485","article-title":"Familial hypercholesterolaemia in patients with ischaemic stroke or transient ischaemic attack","volume":"25","author":"T Toell","year":"2018","journal-title":"Eur J Neurol"},{"issue":"5","key":"pone.0273896.ref032","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jacl.2015.07.005","article-title":"Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit","volume":"9","author":"J Pang","year":"2015","journal-title":"J Clin Lipidol"},{"key":"pone.0273896.ref033","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2015.03.027","article-title":"Prevalence and treatment of familial hypercholesterolaemia in Australian communities","volume":"185","author":"GF Watts","year":"2015","journal-title":"Int J Cardiol"},{"issue":"2","key":"pone.0273896.ref034","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jacl.2019.01.009","article-title":"Comparative aspects of the care of familial hypercholesterolemia in the \"Ten Countries Study\"","volume":"13","author":"J Pang","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"2","key":"pone.0273896.ref035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ihj.2018.12.004","article-title":"Prevalence of familial hypercholesterolemia in premature coronary artery disease patients admitted to a tertiary care hospital in North India","volume":"71","author":"JPS Sawhney","year":"2019","journal-title":"Indian Heart J"},{"issue":"19","key":"pone.0273896.ref036","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.jacc.2019.02.059","article-title":"Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction","volume":"73","author":"A Singh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"pone.0273896.ref037","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijcard.2017.10.105","article-title":"Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey","volume":"252","author":"P Faggiano","year":"2018","journal-title":"Int J Cardiol"},{"issue":"36","key":"pone.0273896.ref038","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/eurheartj\/ehv289","article-title":"Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes","volume":"36","author":"D Nanchen","year":"2015","journal-title":"Eur Heart J"},{"issue":"14","key":"pone.0273896.ref039","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jacc.2017.08.009","article-title":"Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome","volume":"70","author":"A Amor-Salamanca","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"pone.0273896.ref040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.hlc.2007.06.005","article-title":"Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology","volume":"17","author":"TR Bates","year":"2008","journal-title":"Heart Lung Circ"},{"issue":"6","key":"pone.0273896.ref041","doi-asserted-by":"crossref","first-page":"e0251560","DOI":"10.1371\/journal.pone.0251560","article-title":"Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry","volume":"16","author":"KF Alhabib","year":"2021","journal-title":"PLoS One"},{"issue":"7","key":"pone.0273896.ref042","doi-asserted-by":"crossref","first-page":"580","DOI":"10.5551\/jat.41483","article-title":"Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in Japan","volume":"25","author":"T Teramoto","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"pone.0273896.ref043","author":"Organization WH","year":"2018","journal-title":"Noncommunicable diseases country profiles 2018"},{"issue":"5","key":"pone.0273896.ref044","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.HCR.0000336139.48698.26","article-title":"Changing clinical profile of patients entering cardiac rehabilitation\/secondary prevention programs: 1996 to 2006","volume":"28","author":"MC Audelin","year":"2008","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"pone.0273896.ref045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1471-2458-13-362","article-title":"Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) study","volume":"13","author":"P Mallaina","year":"2013","journal-title":"BMC Public Health"},{"issue":"7","key":"pone.0273896.ref046","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.21037\/jtd.2020.02.47","article-title":"Cardiovascular risk of smoking and benefits of smoking cessation","volume":"12","author":"G Gallucci","year":"2020","journal-title":"J Thorac Dis."},{"key":"pone.0273896.ref047","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1476-511X-13-65","article-title":"Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort","volume":"13","author":"MD Allard","year":"2014","journal-title":"Lipids Health Dis"},{"issue":"7","key":"pone.0273896.ref048","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2019.10298","article-title":"Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease","volume":"322","author":"MS Duncan","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"pone.0273896.ref049","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tcm.2020.03.004","article-title":"Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels","volume":"31","author":"V Bianconi","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"pone.0273896.ref050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacl.2017.12.014","article-title":"Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy","volume":"12","author":"AM Galema-Boers","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"12","key":"pone.0273896.ref051","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/oby.2004.256","article-title":"Abdominal obesity and expression of familial combined hyperlipidemia","volume":"12","author":"CJ van der Kallen","year":"2004","journal-title":"Obes Res"},{"issue":"1","key":"pone.0273896.ref052","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"F Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"pone.0273896.ref053","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.04.011","article-title":"Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic","volume":"229","author":"M Futema","year":"2013","journal-title":"Atherosclerosis"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0307980","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0273896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T17:42:35Z","timestamp":1662140555000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0273896"}},"subtitle":[],"editor":[{"given":"Xiao-Feng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0273896","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0307980","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]}}}